| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/30/1998 | WO1998032738A1 New compounds with hemoregulating effect |
| 07/30/1998 | WO1998032734A1 SUBSTITUTED β-THIOCARBOXYLIC ACIDS |
| 07/30/1998 | WO1998032733A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 07/30/1998 | WO1998032732A1 5-aroylnaphthalene derivatives |
| 07/30/1998 | WO1998032730A1 Aminobenzophenones as inhibitors of interleukin and tnf |
| 07/30/1998 | WO1998032724A1 Novel tetralone or benzopyranone derivatives and process for producing the same |
| 07/30/1998 | WO1998032718A1 New fatty acid derivatives |
| 07/30/1998 | WO1998032467A2 Method and conjugate for treating h. pylori infection |
| 07/30/1998 | WO1998032465A1 Composition for the transdermal administration of steroid drugs |
| 07/30/1998 | WO1998032463A2 Lyophilizate of lipid complex of water insoluble porphyrins |
| 07/30/1998 | WO1998032462A1 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination |
| 07/30/1998 | WO1998032460A1 Methods for diagnosing and treating body weight related disorders in animals |
| 07/30/1998 | WO1998032456A1 Identification of broadly reactive dr restricted epitopes |
| 07/30/1998 | WO1998032453A1 Facilitation of wound healing with cm101/gbs toxin |
| 07/30/1998 | WO1998032452A1 Treatment of chronic inflammatory diseases with cm101/gbs toxin |
| 07/30/1998 | WO1998032451A1 Treatment of autoimmune disease using tolerization in combination with methotrexate |
| 07/30/1998 | WO1998032448A1 Facilitation of repair of neural injury with cm101/gbs toxin |
| 07/30/1998 | WO1998032446A1 Urease-responsive delivery systems for diagnostic and therapeutic applications |
| 07/30/1998 | WO1998032445A1 Use of dehydroepiandrosterone to treat primary adrenal insufficiency and addison's disease |
| 07/30/1998 | WO1998032444A1 USE OF FXR, PPARα AND LXRα ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION |
| 07/30/1998 | WO1998032443A1 Ultramicro-emulsions of spontaneously dispersible concentrates containing antitumorally, antivirally and antiparasitically active esters of pentacyclic triterpenes |
| 07/30/1998 | WO1998032442A1 Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as medicines for treating aids |
| 07/30/1998 | WO1998032441A1 Use of central cannabinoid receptor antagonists for regulating appetence |
| 07/30/1998 | WO1998032440A1 Kit for inhibiting the growth of cancers, comprising a chemotherapeutic agent and a benzimidazole, and optionally a potentiator |
| 07/30/1998 | WO1998032439A1 Il-8 receptor antagonists |
| 07/30/1998 | WO1998032438A1 Il-8 receptor antagonists |
| 07/30/1998 | WO1998032437A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more psychiatric disorders |
| 07/30/1998 | WO1998032436A1 Treatment for premenstrual dysphoric disorder |
| 07/30/1998 | WO1998032434A1 New analgesic composition |
| 07/30/1998 | WO1998032431A1 Antigen inducers, vaccine precursors, vaccines, antibodies, neutralizing antibodies, antitoxins, idiotypic antibodies, and anti-idiotypic antibodies induced by the idiotypic antibodies |
| 07/30/1998 | WO1998032430A1 Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid |
| 07/30/1998 | WO1998032429A2 P2 receptor agonists, antagonists and modulators of endogenous atp release for the treatment of skin conditions and the improvement of wound healing |
| 07/30/1998 | WO1998032428A2 Compositions comprising choline and use of choline to treat endotoxic shock |
| 07/30/1998 | WO1998032425A1 Pharmaceutical formulations with delayed drug release |
| 07/30/1998 | WO1998032424A1 PULSATILE DELIVERY OF DILTIAZEM HCl |
| 07/30/1998 | WO1998032422A1 Pharmaceutical preparations and methods for their regional administration |
| 07/30/1998 | WO1998032421A1 Ophthalmic compositions including glycerin and propylene glycol |
| 07/30/1998 | WO1998032415A1 Monohydric alcohol derived urethanes and their use in cosmetic formulations |
| 07/30/1998 | WO1998027108A3 New amide compounds and their use as nitric oxide synthase inhibitors |
| 07/30/1998 | WO1998025598A3 Methods and pharmaceutical compositions for inhibiting tumour cell growth |
| 07/30/1998 | WO1998024780A3 Substituted pyrimidinone and pyridinone compounds and their use |
| 07/30/1998 | WO1998023565A3 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 07/30/1998 | WO1998017313A3 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases |
| 07/30/1998 | WO1998014168A3 Dosage form providing a sustained and ascending drug release |
| 07/30/1998 | DE19803003A1 5-Aroylnaphthalinderivate 5-Aroylnaphthalinderivate |
| 07/30/1998 | DE19802350A1 Sulfamid-Metalloprotease-Inhibitoren Sulfamide metalloprotease inhibitors |
| 07/30/1998 | DE19718245C1 Synthetic tri:glyceride(s) useful as food additives |
| 07/30/1998 | DE19703131A1 Verwendung von Chinoxalin in Dreier-Kombination mit Protease-Inhibitoren und Reverse Transkriptaseinhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen Use of quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as drugs for the treatment of AIDS and / or HIV infection |
| 07/30/1998 | DE19650352A1 New male oral contraceptive composition |
| 07/30/1998 | CA2626424A1 Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid |
| 07/30/1998 | CA2456777A1 Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
| 07/30/1998 | CA2278924A1 Method and conjugate for treating h. pylori infection |
| 07/30/1998 | CA2278779A1 Substituted amino bicyclic-.beta.-lactam penam and cepham derivatives as cysteine protease inhibitors |
| 07/30/1998 | CA2278773A1 Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as medicines for treating aids |
| 07/30/1998 | CA2278739A1 Thiazole benzenesulfonamides as .beta.3 agonists for the treatment of diabetes and obesity |
| 07/30/1998 | CA2278663A1 Urease-responsive delivery systems for diagnostic and therapeutic applications |
| 07/30/1998 | CA2278661A1 Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour reguler l'appetance |
| 07/30/1998 | CA2278603A1 Process for the production of semi synthetic statins via novel intermediates |
| 07/30/1998 | CA2278594A1 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination |
| 07/30/1998 | CA2278504A1 Il-8 receptor antagonists |
| 07/30/1998 | CA2278427A1 Il-8 receptor antagonists |
| 07/30/1998 | CA2278296A1 Identification of broadly reactive dr restricted epitopes |
| 07/30/1998 | CA2278152A1 Treatment of autoimmune disease using tolerization in combination with methotrexate |
| 07/30/1998 | CA2278123A1 Use of fxr, ppar.alpha. and lxr.alpha. activators to restore barrier function, promote epidermal differentiation and inhibit proliferation |
| 07/30/1998 | CA2277970A1 Composition for the transdermal administration of steroid drugs |
| 07/30/1998 | CA2277333A1 Tetrahydrofuran derivatives |
| 07/30/1998 | CA2277166A1 Kit for inhibiting the growth of cancers, comprising a chemotherapeutic agent and a benzimidazole, and optionally a potentiator |
| 07/30/1998 | CA2276691A1 Methods for diagnosing and treating body weight related disorders in animals |
| 07/30/1998 | CA2275777A1 Treatment for premenstrual dysphoric disorder |
| 07/30/1998 | CA2270884A1 Single pot process for producing (z)-azabicyclo oxime ethers |
| 07/30/1998 | CA2269683A1 Method of making (1s, 4r)-1-azabicyclo¬2.2.1|heptan-3-one and (1r, 4s), 1-azabicyclo¬2.2.1|heptan-3-one |
| 07/29/1998 | EP0855444A2 Aspartic proteinase 2 (ASP2) |
| 07/29/1998 | EP0855443A2 cDNA clone HE8CH90 that encodes a 7-transmembrane receptor |
| 07/29/1998 | EP0855402A1 Novel terpenoid compound 0406TP-1 |
| 07/29/1998 | EP0855397A1 (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridine-carboxamide, process for producing the same and medicinal composition containing the same |
| 07/29/1998 | EP0855396A1 Thioctic acid metabolites and methods of use thereof |
| 07/29/1998 | EP0855392A2 Five-membered heterocycles having biphenylsulphonyl substituents, processes for the preparation thereof, their use as medicaments or diagnostic agent and medicaments containing them |
| 07/29/1998 | EP0855391A1 Novel isoquinoline derivatives |
| 07/29/1998 | EP0855389A2 A 3,7-dithiaprostanoic acid derivative |
| 07/29/1998 | EP0855191A2 Methods for treating non-suturable, superficial wounds by use of cyanoacrylate ester compositions comprising an antimicrobial agent |
| 07/29/1998 | EP0855185A2 Host-vector system for use in gene therapy |
| 07/29/1998 | EP0855184A1 Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination |
| 07/29/1998 | EP0855183A2 Manufacture of taste-masked preparations of antibacterial quinolone derivatives |
| 07/29/1998 | EP0855182A1 3-Deoxyglucosone production inhibitor |
| 07/29/1998 | EP0855181A2 Medicament or nutritional formulation for immune-modulation with amino acids |
| 07/29/1998 | EP0855180A1 Antibacterial agents and cosmetics and clothes containing the same |
| 07/29/1998 | EP0855024A1 Histone deacetylase as target for antiprotozoal agents |
| 07/29/1998 | EP0854930A1 Pharmaceutical composition useful for nucleic acid transfection, and use thereof |
| 07/29/1998 | EP0854928A2 Multi-functional hematopoietic receptor agonists |
| 07/29/1998 | EP0854922A1 Improvements in or relating to protection against intracellular infection |
| 07/29/1998 | EP0854914A1 Live vaccines against gram-negative pathogens, expressing heterologous o-antigens |
| 07/29/1998 | EP0854885A1 Recombinant anti-cd4 antibodies for human therapy |
| 07/29/1998 | EP0854881A1 IDENTIFICATION OF sel-12 AND USES THEREOF |
| 07/29/1998 | EP0854879A2 Novel 5-o-deosaminyl 6-o-methyl erythronolide a derivatives, preparation method therefor and use thereof for preparing biologically active materials |
| 07/29/1998 | EP0854878A1 Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| 07/29/1998 | EP0854875A1 New cephem compounds |
| 07/29/1998 | EP0854874A1 Macrocyclic lactone compounds and their production process |
| 07/29/1998 | EP0854870A1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 07/29/1998 | EP0854869A1 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 07/29/1998 | EP0854868A1 Substituted hydroisoquinoline derivatives and their use as pharmaceuticals |